Intelligent Bio Solutions Inc.
INBS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001725430
No open-market purchases or sales by Intelligent Bio Solutions Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $416.2K in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Intelligent Bio Solutions Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 10 | 5 | −5 |
| Shares | 376.7K | 226.2K | −150.5K (−39.9%) |
| Value | $75.1K | $650.9K | +$575.7K (+766.3%) |
New holders (2)
Institutions that held Intelligent Bio Solutions Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 126,650 | $367.3K | 1.37% |
| Walleye Capital LLC | 96,068 | $273.8K | 0.01% |
Sold out (7)
Institutions that held Intelligent Bio Solutions Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Geode Capital Management, LLC | 115,363 | $23.0K |
| Renaissance Technologies LLC | 104,800 | $21.0K |
| Citadel Advisors LLC | 69,481 | $13.9K |
| State Street Corp | 34,115 | $6.82K |
| Vanguard Group Inc | 16,916 | $3.38K |
| StoneX Group Inc. | 13,145 | $2.63K |
| Jane Street Group, LLC | 11,202 | $2.24K |